Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging (Amsterdam)

This study has been terminated.
(Lack of patient population)
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
Information provided by (Responsible Party):
Piedmont Healthcare Identifier:
First received: January 31, 2011
Last updated: September 4, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)